What is the appropriate dosing for Megace (Megestrol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The appropriate dosing for Megace (Megestrol) is 200-600 mg/d, with a suggested optimal dose between 400-800 mg/d.

Key Points

  • The dosing range of 200-600 mg/d is based on the ASCO guideline for the management of cancer cachexia 1.
  • A systematic review of 29 trials using progestins, including megestrol acetate, suggested that the optimal dose is between 480 and 800 mg per day 1.
  • The minimum efficacious dose is 160 mg/day, but there is no evidence that doses greater than 480 mg/day have a higher efficacy 1.
  • The NCCN guidelines recommend a dose of 400-800 mg/d for the treatment of anorexia/cachexia in patients with advanced cancer 1.

Benefits and Risks

  • Megestrol acetate has been shown to improve appetite and weight gain in patients with cancer cachexia, but may increase the risk of edema, thromboembolism, and adrenal insufficiency 1.
  • The benefits and risks of megestrol acetate should be carefully considered and monitored in patients with cancer cachexia.

Clinical Considerations

  • Megestrol acetate can be used in combination with other interventions, such as dietary counseling and oral nutritional supplements, to manage cancer cachexia.
  • The dose and duration of megestrol acetate should be individualized based on patient response and tolerance.
  • Regular monitoring of patients receiving megestrol acetate is necessary to minimize the risk of adverse events and optimize treatment outcomes.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION The recommended adult initial dosage of megestrol acetate oral suspension, USP is 800 mg/day (20 mL/day). In clinical trials evaluating different dose schedules, daily doses of 400 and 800 mg/day were found to be clinically effective.

The appropriate dosing for Megace (Megestrol) is:

  • Initial dosage: 800 mg/day (20 mL/day)
  • Effective daily doses: 400 mg/day and 800 mg/day 2

From the Research

Appropriate Dosing for Megace (Megestrol)

The appropriate dosing for Megace (Megestrol) can vary depending on the patient population and the specific condition being treated.

  • For cancer anorexia/cachexia, a study found that megestrol acetate was well tolerated and had a positive dose-response effect on appetite stimulation, with doses ranging from 160 to 1,280 mg/d 3.
  • However, due to cost and inconvenience, the study suggests using 160 mg/d as the initial treatment dose for cancer anorexia/cachexia in routine clinical practice 3.
  • Another study found that 80 mg twice daily after meals is an appropriate starting dose of megestrol acetate for anorexia in advanced cancer, with possible dose escalation if needed 4.
  • For maintenance dialysis patients, a study found that megestrol acetate in a moderate dose of 400 mg/day was safe and improved nutritional state, inflammation, and anorexia 5.
  • A randomized, double-blind, placebo-controlled trial compared megestrol acetate 480 mg/day with dexamethasone 4 mg/day for treating symptomatic anorexia in people with advanced cancer, and found that 79.3% of patients in the megestrol group responded to treatment at week 1 6.

Key Findings

  • Megestrol acetate has a positive dose-response effect on appetite stimulation in cancer anorexia/cachexia patients 3.
  • The initial treatment dose for cancer anorexia/cachexia is suggested to be 160 mg/d due to cost and inconvenience 3.
  • A moderate dose of 400 mg/day may be effective for maintenance dialysis patients 5.
  • Megestrol acetate 480 mg/day may be effective for treating symptomatic anorexia in people with advanced cancer 6.

Dosing Considerations

  • Dosing regimens may vary depending on the patient population and specific condition being treated 3, 4, 5, 6.
  • Possible side effects, such as altered mood and insomnia, should be considered when determining the appropriate dose 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993

Research

Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.